Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Hepatitiden

Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study. 

Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study. 

Buggisch P, Heiken H, Mauss S, Weber B, Jung MC, Görne H, Heyne R, Hinrichsen H, Hidde D, König B, Pires Dos Santos AG, Niederau C, Berg T. 

PLoS One. 2021 May 10;16(5):e0250833. doi: 10.1371/journal.pone.0250833. PMID: 33970940; PMCID: PMC8109809.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250833